Ivensoa 6mg Tablet contains Ivermectin, an antiparasitic agent effective against a variety of parasitic infections. Ivermectin works by binding selectively and with high affinity to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, leading to increased permeability to chloride ions, hyperpolarization, and eventual paralysis and death of the parasite. This medication is primarily indicated for the treatment of onchocerciasis (river blindness), strongyloidiasis, and other parasitic infestations caused by susceptible organisms. Ivensoa 6mg Tablet is administered orally, with dosage and duration determined by the type and severity of the infection, as well as patient-specific factors. It is generally well tolerated, but common adverse effects may include dizziness, nausea, diarrhea, and mild skin reactions. Caution is advised in patients with a history of hypersensitivity to Ivermectin or other components of the formulation. Use during pregnancy and lactation should be under strict medical supervision. Ivensoa should be stored in a cool, dry place, away from direct sunlight and out of reach of children. Proper adherence to prescribed dosage is essential to ensure therapeutic efficacy and minimize the risk of resistance development. Always consult a healthcare professional before initiating treatment with Ivensoa 6mg Tablet.